Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
424.3 DKK | +1.05% | +1.41% | +14.66% |
May. 10 | NOVONESIS : Key segments outperform in average Q1 24 showing | |
May. 03 | Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.66% | 28.1B | |
-14.02% | 3.79B | |
+12.14% | 1.8B | |
-10.77% | 637M | |
-27.39% | 389M | |
-81.65% | 216M |
- Stock Market
- Equities
- NSIS B Stock
- News Novonesis A/S
- FMC Partners With Novonesis in Canada for Biosolution Products